Practice Management News

Led by Rohit Loomba, MD, MHSc, professor of medicine in the division of gastroenterology, University of California San Diego, the University of California San Diego School of Medicine announced it has launched a new nonalcoholic fatty liver disease research center to help better understand the disease and develop treatments.

The U.S. Senate health committee today recommended legislation to strengthen and increase the visibility of medical rehabilitation research at the NIH.

The U.S. Senate Committee on Health, Education, Labor and Pensions adopted legislation today designed to speed up development of genetically targeted drugs for patients with rare and serious or life-threating conditions.

The U.S. Senate Committee on Health, Education, Labor and Pensions will consider seven bipartisan bills on biomedical innovation tomorrow, Feb. 9, at the first of three executive sessions.

The ABIM has announced several new efforts aimed at including internists and subspecialists in the process of improving Maintenance of Certification assessments, according to a press release.

The American College of Gastroenterology has released a clinical practice guideline for the diagnosis, treatment and management of various forms of liver disease among pregnant women.

The National Cancer Centre Singapore, Singapore Clinical Research Institute and IMS Health announced a collaboration to develop its first hepatocellular carcinoma registry in Asia via the Asian HCC Physician Network, in an effort to better manage patients, according to a press release.

A majority of Alaska natives showed signs of protection against hepatitis B virus infection 30 years after receiving a primary vaccination series, suggesting booster doses are not needed, according to published findings.

About 88% of executives of heath care organizations reported that use of an electronic health record system resulted in a positive outcome, according to a survey from the Healthcare Information and Management Systems Society, or HIMSS.

Many chronic pain patients ignore labels on over-the-counter pain relievers and increase their risk for overdose and gastrointestinal side effects, according to results from a new AGA survey.